Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

¿Te ayudamos?

Ejemplos de búsqueda

Vídeos Explicativos

SCENTINEL

Financiado

Cerrado

BUILDING INTEGRATIVE SINGLE CELL OMICS CAPACITIES USING INVERTEBRATE TUMOR MODEL...

BUILDING INTEGRATIVE SINGLE CELL OMICS CAPACITIES USING INVERTEBRATE TUMOR MODELS RELEVANT TO HUMAN DISEASE SCENTINEL aims to elevate the international status of FORTH, Greece by enhancing its Genomics and Bioinformatics capacities, which are presently underdeveloped. For this reason, FORTH-IMBB twins with four major European research i... ver más

31/05/2027

Líder desconocido

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto Líder desconocido

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-03-22

HORIZON-WIDERA-2023-ACCESS-02-01: Twinning Bottom-Up Expected Outcome:For the first time this Twinning call adopts a partially directional approach allow...

Innovación

Cerrada hace 1 año

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

Participantes

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 38 meses Fecha Inicio: 2024-03-22
Fecha Fin: 2027-05-31

Líder del proyecto Líder desconocido

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto SCENTINEL aims to elevate the international status of FORTH, Greece by enhancing its Genomics and Bioinformatics capacities, which are presently underdeveloped. For this reason, FORTH-IMBB twins with four major European research institutions: the IGBMC a component institute of the CERBM (Strasbourg), the CNRS Insitut Jacques Monod (Paris), Stockholm University and the IRB (Barcelona). Our scientific vessel will exploit Drosophila neural cancer models, to address fundamental questions about tumorigenesis, tumor composition and tumor-microenvironment interactions. In the long-term, our results may prove relevant for human cancer diagnosis and treatment, achieving a tangible impact of wider benefit to society. Our action plan will include both network-wide actions (hands-on workshops, virtual and in-person network meetings) and individualized training (e.g. inter-lab visits, training of facility personnel. training of operational officers in research management). Dissemination and communication activities will target the scientific community (conferences, seminars, high-impact publications), authorities and financial stakeholders (forums, open days) and the general public (digital media, science popularization presentations). Young and senior scientists of the network will benefit by engaging in excellent research and acquiring scientific skills in cutting-edge technologies, as well as soft skills necessary for mobility across EU Academia and Industry. Via SCENTINEL, FORTH-IMBB will emerge as a leader in advanced genomics & bioinformatics and will make its services available not only to the local biomedical community, but also to the wider area of Southeastern Europe. The upgraded FORTH R&I capacities will stimulate retention and recruitment of highly motivated, internationally competitive scientists, improving its human capital. The strengthened links among participating institutes will promote collaborations beyond the duration of this project and ensure success in future funding for innovative research.

Conecta tu I+D

Entra hoy

Forgot your password?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores